Medicare Enrolled
Dr. Alfret Moradian, M.D
Family Medicine · Glendale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Moradian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moradian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Moradian
Dr. Alfret Moradian is a family medicine specialist in Glendale, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Moradian performed 4,200 Medicare services across 2,049 unique beneficiaries.
Between the years covered by Open Payments, Dr. Moradian received a total of $13,617 from 41 pharmaceutical and/or device companies across 439 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Moradian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 4% volume in CA
$13,617 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,200
Medicare services
Top 4% in CA for family medicine
2,049
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~247 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,475 | $72 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
453 | $68 | $171 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
417 | $102 | $177 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
286 | $8 | $12 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
221 | $144 | $181 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
219 | $68 | $160 |
| Annual depression screening | 217 | $21 | $50 |
| Annual alcohol misuse screening, 5 to 15 minutes | 213 | $21 | $50 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
135 | $146 | $249 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
123 | $28 | $60 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
82 | $12 | $47 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
49 | $70 | $171 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
45 | $37 | $61 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
40 | $73 | $77 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
40 | $16 | $127 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
40 | $34 | $61 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $105 | $160 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
37 | $110 | $250 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
25 | $182 | $198 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
17 | $183 | $271 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $146 | $210 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $79 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,617
Total received (2018-2024)
Avg $1,945/year across 7 years
Top 3% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
439
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,617 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,855
2023
$1,854
2022
$2,851
2021
$1,170
2020
$984
2019
$2,677
2018
$2,226
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$268
Boehringer Ingelheim Pharmaceuticals, Inc.
$239
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$219
Ardelyx, Inc.
$193
Esperion Therapeutics, Inc.
$189
ABBVIE INC.
$147
Lilly USA, LLC
$145
Phathom Pharmaceuticals, Inc.
$125
Madrigal Pharmaceuticals
$121
AstraZeneca Pharmaceuticals LP
$88
SHIELD THERAPEUTICS INC
$29
AIMMUNE THERAPEUTICS, INC.
$27
Novartis Pharmaceuticals Corporation
$27
SCILEX PHARMACEUTICALS INC.
$21
Bayer Healthcare Pharmaceuticals Inc.
$15
Top 3 companies account for 39.2% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,812
Amgen Inc.
$1,383
Lilly USA, LLC
$1,032
AstraZeneca Pharmaceuticals LP
$896
ABBVIE INC.
$788
Esperion Therapeutics, Inc.
$758
Boehringer Ingelheim Pharmaceuticals, Inc.
$697
Novo Nordisk Inc
$697
Amarin Pharma Inc.
$627
Synergy Pharmaceuticals Inc
$620
Abbott Laboratories
$542
Ironwood Pharmaceuticals, Inc
$314
GlaxoSmithKline, LLC.
$283
Janssen Pharmaceuticals, Inc
$249
Bayer Healthcare Pharmaceuticals Inc.
$239
AbbVie, Inc.
$225
PFIZER INC.
$222
E.R. Squibb & Sons, L.L.C.
$208
Ardelyx, Inc.
$193
Takeda Pharmaceuticals U.S.A., Inc.
$174
Teva Pharmaceuticals USA, Inc.
$141
Kowa Pharmaceuticals America, Inc.
$139
ABIOMED
$138
IRONWOOD PHARMACEUTICALS, INC
$133
Phathom Pharmaceuticals, Inc.
$125
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$123
Regeneron Healthcare Solutions, Inc.
$122
Madrigal Pharmaceuticals
$121
Bayer HealthCare Pharmaceuticals Inc.
$120
AbbVie Inc.
$118
SANOFI-AVENTIS U.S. LLC
$85
Nestle HealthCare Nutrition Inc.
$50
Arbor Pharmaceuticals, Inc.
$42
Merck Sharp & Dohme Corporation
$35
SHIELD THERAPEUTICS INC
$29
AIMMUNE THERAPEUTICS, INC.
$27
Novartis Pharmaceuticals Corporation
$27
Merck Sharp & Dohme LLC
$24
SCILEX PHARMACEUTICALS INC.
$21
ARBOR PHARMACEUTICALS, INC.
$21
Allergan Inc.
$17
Top 3 companies account for 31.0% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AJOVY · AMPLATZER Occluders · ANORO · APRISO · Aimovig · Amitiza · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · CHANTIX · CREON · ELIQUIS · EMGALITY · EVENITY · Edarbi · FARXIGA · Horizant · IBSRELA · Impella · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LYRICA · LifeVest · Linzess · Livalo · MITRACLIP · MOTEGRITY · MOUNJARO · Motegrity · NEXLETOL · NEXLIZET · Otezla · Ozempic · PRALUENT · PREVNAR - 13 · Prolia · REZDIFFRA · Repatha · Rybelsus · Seglentis · TRADJENTA · TRELEGY ELLIPTA · TRULANCE · TRULICITY · Trulance · VERQUVO · VIBERZI · VOQUEZNA · Vascepa · XARELTO · XIFAXAN · Xience V coronary stent system · ZENPEP · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
2,881
Per 100K population
29.3
County median income
$87,760
Nearest hospital
USC VERDUGO HILLS HOSPITAL
1.4 mi
1.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Moradian is a clinical cardiology specialist, with above-average Medicare volume (top 4% in CA), with low-engagement industry engagement in the top 3% of CA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Moradian experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Moradian performed 1,475 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Moradian receive payments from pharmaceutical companies?
Yes. Dr. Moradian received a total of $13,617 from 41 companies across 439 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moradian's costs compare to other family medicine physicians in Glendale?
Dr. Moradian's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moradian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Glendale
Browse family medicine physicians in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology